Researchers at Washington University and Stanford developed a cannabinoid compound that provides pain relief without ...
A study published in the journal Decision Analysis unveils a powerful new tool to tackle the opioid crisis, offering a pathway to slash costs by nearly 30% while saving lives.
By Alexandra Alter When Barbara Kingsolver was writing “Demon Copperhead,” a novel that explores the devastating effects of the opioid crisis in southern Appalachia, she was doubtful that ...
Persica Pharma announces positive phase 1b Modic trial of PP353, a novel, non-opioid intradiscal injection to treat chronic low back pain: London, UK Thursday, March 6, 2025, 18:0 ...
SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...
The opioid-free group also had improved comfort and satisfaction scores. Perspective from Asif M. Ilyas, MD, MBA, FAAOS According to published results, a novel opioid-free pathway may provide ...
The global opioid analgesics market is poised for substantial growth, projected to expand from USD 43.3 billion in 2023 to USD 72.0 billion by 2033, at a robust Compound Annual Growth Rate (CAGR) of 5 ...
The firm sees Journavx as the first in a series of novel non-opioid pain medicines coming from Vertex. Risinger said Leerink projects Journavx and follow-on NaV1.8 inhibitors for acute and ...
DOI: 10.1287/deca.2023.0084 Provided by Institute for Operations Research and the Management Sciences Citation: Novel tool slashes opioid crisis costs by 30%, could save lives (2025, February 20 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback